Delivery Order SPE2DB22D3301-SPE2DB25FY4YA
Award Date
5/16/25
Potential Completion Date
5/19/25
Potential Value
$41K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ENBREL 50 mg/mL syringes, a medication used to treat certain autoimmune diseases. The contract has a ceiling value of $6,981.73 and a performance period ending on May 2, 2025. This award is not set aside and represents an open competition. AmerisourceBergen Drug Corp holds a $999,999,999.00...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENBREL 50 MG/ML SYRINGEML. The contract has a ceiling value of $61,017.59 and a period of performance through October 6, 2023. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,093,165 units of Enbrel 50 mg/ml syringe, a medication used to treat autoimmune disorders. The contract has a ceiling value of $4,787.86 and a period of performance through May 1, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a substantial...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $28,844.82, is for the delivery of ENBREL 50 MG/ML SYRINGE/ML, a specialty pharmaceutical product. The contract has an ultimate completion date of October 25, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $12,243.84 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENBREL 50 MG/ML SYRINGEML, a specialty medication, with a period of performance through February 14, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,301.10, is for the provision of ENBREL 50 MG/ML syringes, a medication used to treat various autoimmune disorders. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 2, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a $18,058.07 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENBREL 50 MG/ML SYRINGEML, a medication used to treat certain inflammatory conditions. The contract has an ultimate completion date of April 9, 2025 and was awarded on April 8, 2025. There is no set-aside designation for this...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ENBREL 25 MG/0.5 ML syringes, a specialty pharmaceutical product. The contract has a firm fixed price, with a ceiling value of $6,067.06, and a period of performance through May 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $67,817.54, is for the provision of ENBREL 50 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of May 29, 2024 and is a firm fixed-price delivery order. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a federal delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Enbrel 50 mg/mL syringes, a specialty medication used to treat various autoimmune conditions. The fixed-price delivery order has a ceiling value of $11,260.80 and an ultimate completion date of November 3, 2023. Amerisourcebergen...